عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
شابک
شابک
0896039188
شابک
1592593348
شابک
9780896039186
شابک
9781592593347
شماره کتابشناسی ملی
شماره
b544994
عنوان و نام پديدآور
عنوان اصلي
Recombinant Antibodies for Cancer Therapy :
نام عام مواد
[Book]
ساير اطلاعات عنواني
Reviews and Protocols.
نام نخستين پديدآور
Martin Welschof
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Totowa
نام ناشر، پخش کننده و غيره
Humana Press
تاریخ نشرو بخش و غیره
2002
مشخصات ظاهری
نام خاص و کميت اثر
(497 pages).
فروست
عنوان فروست
Methods in molecular biology Recombinant antibodies for cancer therapy
یادداشتهای مربوط به مندرجات
متن يادداشت
Recombinant Antibodies for Cancer Therapy"; "Preface"; "Contents"; "Contributors"; "INTRODUCTION"; "1 Generation of Antibody Molecules Through Antibody Engineering"; "2 Application of Recombinant Antibodies in Cancer Patients"; "HYBRIDOMA-DERIVED ANTIBODIES"; "3 DNA Immunization as a Means to Generate Antibodies to Proteins"; "4 Chimerization of a Monoclonal Antibody for Treating Hodgkin�s Lymphoma"; "5 Humanization of Monoclonal Antibodies by CDR Grafting"; "RECOMBINANT ANTIBODY FRAGMENTS FROM PHAGEMID-DISPLAYED ANTIBODY REPERTOIRES" "6 Generation and Screening of a Modular Human scFv Expression Library from Multiple Donors""7 Construction of Semisynthetic Antibody Libraries"; "8 Single-Domain VH Antibody Fragments from a Phage Display Library"; "9 Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selection"; "10 Human Recombinant Fab Antibodies with T-Cell Receptor-Like Specificities Generated from Phage Display Libraries"; "11 Engineering Hot Spots for Affinity Enhancement of Antibodies"; "12 Simultaneous Humanization and Affinity Optimization of Monoclonal Antibodies" "13 Tailoring Kinetics of Antibodies Using Focused Combinatorial Libraries""ANTIBODY FRAGMENTS WITH ADDITIONAL PROPERTIES"; "14 Engineering scFvs for Improved Stability"; "15 Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer Therapy"; "16 Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules"; "17 Construction and Characterization of RNase-Based Targeted Therapeutics"; "18 Bispecific Diabodies for Cancer Therapy" "19 Generation and Characterization of Bispecific Tandem Diabodies for Tumor Therapy""20 Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy"; "21 Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas"; "22 Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy"; "23 Tailoring Natural Effector Functions Antibody Engineering Beyond Humanization"; "24 Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development" "25 Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments""LARGE SCALE PRODUCTION OF RECOMBINANT ANTIBODIES FOR CLINICAL APPLICATION"; "26 Production of Antibody Fragments in a Bioreactor"; "27 Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains"; "28 Production of Tumor-Specific Antibodies in Tobacco"; "Index"
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Cancer -- Immunotherapy -- Laboratory manuals.
موضوع مستند نشده
Cancer -- Immunotherapy.
موضوع مستند نشده
Recombinant antibodies.
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )
مستند نام اشخاص تاييد نشده
Martin Welschof
نام شخص - (مسئولیت معنوی برابر )
مستند نام اشخاص تاييد نشده
Jurgen Krauss
مستند نام اشخاص تاييد نشده
Martin Welschof
دسترسی و محل الکترونیکی
نام الکترونيکي
مطالعه متن کتاب اطلاعات رکورد کتابشناسی
نوع ماده
[Book]
اطلاعات دسترسی رکورد
تكميل شده
Y
